Remove Clinical Research Remove Pharma Companies Remove Treatment
article thumbnail

Why Do Pharma Companies Outsource to CROs?

Vial

Sponsors often contract a CRO to delegate specific day-to-day tasks, streamlining their research processes and enhancing efficiency. Patient recruitment and retention : Recruiting and retaining a sufficient number of eligible participants is one of the major challenges in conducting clinical trials.

article thumbnail

Four Ideas for Pharma to Maximize the Influence of Digital Opinion Leaders in Medicine

H1 Blog

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Keeping tabs on Covid-19: BetterLife embraces virtual clinical trials and Novan shares positive results from in vitro antiviral technology against SARS-CoV-2

The Pharma Data

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. With many nationwide and regional lockdowns coming into force, virtual clinical trials are proving to be an effective way to monitor patients remotely.

article thumbnail

The Opportunities and Challenges of Improving Health Equity with Expert Daniel Perez

H1 Blog

Worldwide Clinical Trials is a leading full-service global CRO (contract research organization) working with biotech and pharma to create customized solutions. Perez spoke about the opportunities and challenges in health equity and the role of pharma companies and CROs to drive more equitable research.

article thumbnail

Best Practices in Pre-Screening Includes Use of Technology

Advarra

What is Pre-Screening in Clinical Research? In one case study exploring its application across four trials of a top-10 pharma company, the solution’s efforts accounted for 94 percent of trial participants who eventually enrolled. Pre-screening activities take place at the outset of a trial, before informed consent.

article thumbnail

BioSpace Movers & Shakers, Dec. 18

The Pharma Data

Most recently, Cadavid served as senior vice president and Head of Clinical Development at Fulcrum Therapeutics where he led the development of multiple small molecules for the treatment of genetically defined rare diseases. AB2 Bio – Swiss pharma company AB2 Bio Ltd. Earlier, she served as CSO at Curis, Inc.

article thumbnail

Women in STEM with Kristina Torfgard

Drug Target Review

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company.